Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699045 | Clinical Oncology | 2012 | 7 Pages |
Abstract
FSRT is highly effective at controlling the growth of ONSMs with improvement or stabilisation of visual deficit in 89% of the optic nerves retaining some vision, albeit with a small risk of radiation-induced retinopathy. The results support the use of FSRT as an effective approach in the management of ONSM. The lack of functional benefit in patients with severe visual impairment would argue for earlier institution of treatment before complete visual loss is established.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
F. Soldà , B. Wharram, R. Gunapala, M. Brada,